{"favorite_id": 10444, "calc_type": "diagnostic_criteria", "dosing": true, "full_title_en": "Indications for Paxlovid", "short_title_en": "Indications for Paxlovid", "medium_description_en": "Assists in determining if Paxlovid (ritonovir-boosted nirmatrelvir) is appropriate therapy in a COVID positive adult patient.", "short_description_en": "Paxlovid indication.", "before_use": "", "instructions_en": "<p>In the United States, Paxlovid (ritonovir-boosted nirmatrelvir), is currently availble under the Food and Drug Administration (FDA) Emergency Use Authorization (EUA). This drug status is subject to change.&nbsp;</p>", "slug": "indications-paxlovid-prescribing", "logic_language": "javascript", "md5": "d08b3e9c470eeee9eef36f44dfa9e3e8", "cmeVersion": null, "cmeReleaseDate": null, "cmeEndDate": null, "cmeLastReviewed": null, "publishedAt": "2022-11-10T14:27:17.155Z", "vuid": "b860d12d-f79e-41ed-b37d-4ec3ac559ae7", "versionNumber": 1, "isVisibleInListView": false, "disabled": false, "replacement_calc_id": null, "disabled_reason": null, "search_abbreviation_en": ["Paxlovid", "covid", "covid 19", "covid-19", "coronavirus", "antiviral therapy", "antiviral prescribing"], "seo": {"meta_description_en": "Indications for Paxlovid Prescribing assists in determining if Paxlovid (ritonovir-boosted nirmatrelvir) is appropriate therapy in a COVID positive adult patient.", "keywords_en": "Paxlovid, covid, covid 19, covid-19, coronavirus, antiviral therapy, antiviral prescribing"}, "content": {"reviewer": {"expert_name": []}, "related_resources": {"mdcalc_rating": [], "guidelines": [], "teaching": [], "videos": [], "interests": [], "partner_contact": [], "sdm_tool": []}, "how_to_use": {"use_case_en": "<p>Do you use Indications for Paxlovid Prescribing and want to contribute your expertise? <a href=\"https://www.mdcalc.com/join-us\" target=\"_blank\" rel=\"noopener\">Join</a> our contributor team!</p>", "pearls_pitfalls_en": "", "why_use_en": ""}, "next_steps": {"advice_en": "<p>Prescribing Information for Paxlovid (ritonavir-boosted nirmatrelvir)</p>\n<ul>\n<li>eGFR &gt;60 mL/min: Nirmatrelvir 300mg with ritonavir 100mg PO twice daily for 5 days.</li>\n<li>eGFR &gt;30 mL/min to &lt;60 mL/min: Nirmatrelvir 150mg with ritonavir 100mg PO twice daily for 5 days.</li>\n<li>eGFR &lt;30 mL/min: This medication is not recommended.</li>\n<li>Severe Hepatic Impairment (Child-Pugh Class C): This medication is not recommended.</li>\n</ul>", "management_en": "<p>Paxlovid is recommended for COVID-19 positive patients in the nonhospitalized setting who are at high risk of progression to severe COVID-19 disease.</p>\n<p>Paxlovid is also recommended for hospitalized patients who were hospitalized for another reason, but who are found to have mild-moderate COVID-19 disease and are at high risk of progression to severe illness.</p>", "critical_actions_en": "<ul>\n<li>Paxlovid may interact with many patient medications. It is important to take a complete medication history and review potential interactions. The CDC recommends using the Liverpool Covid-19 Drug Interactions <a href=\"https://www.covid19-druginteractions.org/checker\" target=\"_blank\" rel=\"noopener\">checker</a>.</li>\n<li>Additional treatment <a href=\"https://www.covid19treatmentguidelines.nih.gov/special-populations/pregnancy/\" target=\"_blank\" rel=\"noopener\">guidance</a> exists for patients who may be pregnant or lactating available from the National Institute of Health, American College of Obstetricians and Gynecologists, and the Society for Maternal-Fetal Medicine.</li>\n<li>Paxlovid is not appropriate for all patients, for the latest on other available oral and IV treatment regimens, please visit the National Institutes of Health (NIH) COVID-19 Treatment Guidelines <a href=\"https://www.covid19treatmentguidelines.nih.gov/\" target=\"_blank\" rel=\"noopener\">website</a>.</li>\n</ul>"}, "about": {"formula_en": "<p>Inclusion criteria (must fulfill all 5 to evaluate for Paxlovid):</p>\n<ul>\n<li>&gt;12 years old and &gt;40 kg</li>\n<li>Mild to moderate COVID-19 disease as defined by the <a href=\"https://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum/\" target=\"_blank\" rel=\"noopener\">NIH</a></li>\n<li>Symptoms began &le;5 days prior</li>\n<li>eGFR &gt;30 mL/min</li>\n<li>Patient does not have severe hepatic impairment (does not have Child-Pugh Class C)</li>\n</ul>\n<p>High risk conditions (having any 1 of the following results is indication for Paxlovid):</p>\n<ul>\n<li>ADHD</li>\n<li>Age &gt;50 years</li>\n<li>Alcoholic liver disease</li>\n<li>Asthma</li>\n<li>Autoimmune hepatitis</li>\n<li>Bronchiectasis</li>\n<li>Cancer</li>\n<li>Cardiomyopathy</li>\n<li>Cerebral palsy</li>\n<li>Cerebrovascular disease</li>\n<li>Chronic kidney disease</li>\n<li>Cirrhosis</li>\n<li>Congenital malformations</li>\n<li>COPD</li>\n<li>Coronary artery disease</li>\n<li>Cystic fibrosis</li>\n<li>Dementia</li>\n<li>Diabetes type 1 or 2</li>\n<li>Heart failure</li>\n<li>HIV</li>\n<li>Intellectual and developmental disabilities</li>\n<li>Interstitial lung disease</li>\n<li>Learning disabilities</li>\n<li>Limitations with self care/ADLs</li>\n<li>Mood disorders</li>\n<li>Nonalcoholic fatty liver disease</li>\n<li>Obesity (BMI &gt;30 or &gt;95th %ile in children)</li>\n<li>Physical inactivity</li>\n<li>Pregnancy</li>\n<li>Primary immunodeficiencies</li>\n<li>Pulmonary embolism</li>\n<li>Pulmonary hypertension&nbsp;</li>\n<li>Schizophrenia spectrum disorders</li>\n<li>Sickle cell or thalassemia</li>\n<li>Smoking history or current smoker</li>\n<li>Solid organ or hematopoietic cell transplantation</li>\n<li>Spinal cord injuries</li>\n<li>Stroke or cerebrovascular disease</li>\n<li>Substance use disorder</li>\n<li>Tuberculosis</li>\n<li>Unvaccinated or not up to date with vaccines</li>\n<li>Use of corticosteroids or other immunosuppressive medications</li>\n</ul>", "more_info_en": "", "evidence_based_medicine_en": "", "references_list": {"Validation": [], "Outcomes": [], "Validations": [], "Original/Primary Reference": [{"text": "Scientific Evidence for Conditions Associated with Higher Risk for Severe COVID-19", "href": "https://www.cdc.gov/coronavirus/2019-ncov/science/science-briefs/underlying-evidence-table.html"}, {"text": "Underlying Medical Conditions Associated with Higher Risk for Severe COVID-19: Information for Healthcare Professionals", "href": "https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/underlyingconditions.html"}], "Other References": [{"text": "FDA Factsheet for Healthcare Providers: Emergency Use Authorization for Paxlovid", "href": "https://www.fda.gov/media/155050/download"}], "Clinical Practice Guidelines": [{"text": "Nonhospitalized Adults: Therapeutic Management of COVID-19", "href": "https://www.covid19treatmentguidelines.nih.gov/management/clinical-management-of-adults/nonhospitalized-adults--therapeutic-management/"}], "Manufacturer Website": []}}, "creator": [{"qa_en": null, "approved": true, "name": "Centers for Disease Control and Prevention ", "creator_info": {"deceased": false, "about_en": "<p>The CDC is the leading\u00a0national public health agency\u00a0in the US. It focuses on\u00a0infectious disease,\u00a0food borne pathogens,\u00a0environmental health,\u00a0occupational safety and health,\u00a0health promotion,\u00a0injury prevention,\u00a0and educational activities designed to improve public health. More information can be found on the <a href=' https://www.cdc.gov/' target='_blank'>CDC website</a>.</p>", "photo_en": "https://cdn-web-img.mdcalc.com/people/cdc-logo.jpg"}}], "contributor": {"expert_name": []}}, "input_schema": [{"type": "subheading", "subheading": "Inclusion criteria", "subheading_instructions": "Must fulfill all 5 to evaluate for Paxlovid"}, {"type": "toggle", "name": "age", "conditionality": null, "optional": false, "default": 0, "label_en": "<p>&gt;12 years old and &gt;40 kg</p>", "show_points": false, "tips_en": "", "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}]}, {"type": "toggle", "name": "disease", "conditionality": null, "optional": false, "default": 0, "label_en": "<p>Mild to moderate COVID-19 disease</p>", "show_points": false, "tips_en": "See <a href=\"https://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum/\" target=\"_blank\" rel=\"noopener\">NIH</a> definitions of mild and moderate disease.", "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}]}, {"type": "toggle", "name": "symptoms", "conditionality": null, "optional": false, "default": 0, "label_en": "<p>Symptoms began &le;5 days prior</p>", "show_points": false, "tips_en": "", "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}]}, {"type": "toggle", "name": "egfr", "conditionality": null, "optional": false, "default": 0, "label_en": "<p>eGFR &gt;30 mL/min</p>", "show_points": false, "tips_en": "", "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}]}, {"type": "toggle", "name": "impairment", "conditionality": null, "optional": false, "default": 0, "label_en": "<p>Patient does not have severe hepatic impairment</p>", "show_points": false, "tips_en": "", "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}]}, {"type": "subheading", "subheading": "Paxlovid criteria", "subheading_instructions": "Having any 1 of the following results is indication for Paxlovid"}, {"type": "dropdown", "label_en": "<p>High risk conditions</p>", "name": "criteria", "default": null, "show_points": false, "optional": true, "conditionality": "age == 1 && disease == 1 && symptoms == 1 && egfr == 1 && impairment == 1", "tips_en": "See <a href='#evidence'>Evidence</a> for full list.", "options": [{"label": "ADHD", "value": 1}, {"label": "Age >50 years", "value": 2}, {"label": "Alcoholic liver disease", "value": 3}, {"label": "Asthma", "value": 4}, {"label": "Autoimmune hepatitis", "value": 5}, {"label": "Bronchiectasis", "value": 6}, {"label": "Cancer", "value": 7}, {"label": "Cardiomyopathy", "value": 8}, {"label": "Cerebral palsy", "value": 9}, {"label": "Cerebrovascular disease", "value": 10}, {"label": "Chronic kidney disease", "value": 11}, {"label": "Cirrhosis", "value": 12}, {"label": "Congenital malformations", "value": 13}, {"label": "COPD", "value": 14}, {"label": "Coronary artery disease", "value": 15}, {"label": "Cystic fibrosis", "value": 16}, {"label": "Dementia", "value": 17}, {"label": "Diabetes type 1 or 2", "value": 18}, {"label": "Heart failure", "value": 19}, {"label": "HIV", "value": 20}, {"label": "Intellectual and developmental disabilities", "value": 21}, {"label": "Interstitial lung disease", "value": 22}, {"label": "Learning disabilities", "value": 23}, {"label": "Limitations with self care/ADLs", "value": 24}, {"label": "Mood disorders", "value": 25}, {"label": "Nonalcoholic fatty liver disease", "value": 26}, {"label": "Obesity (BMI \u226530 or \u226595th %ile in children)", "value": 27}, {"label": "Physical inactivity", "value": 28}, {"label": "Pregnancy", "value": 29}, {"label": "Primary immunodeficiencies", "value": 30}, {"label": "Pulmonary embolism", "value": 31}, {"label": "Pulmonary hypertension", "value": 32}, {"label": "Schizophrenia spectrum disorders", "value": 33}, {"label": "Sickle cell or thalassemia", "value": 34}, {"label": "Smoking history or current smoker", "value": 35}, {"label": "Solid organ or hematopoietic cell transplantation", "value": 36}, {"label": "Spinal cord injuries", "value": 37}, {"label": "Stroke or cerebrovascular disease", "value": 38}, {"label": "Substance use disorder", "value": 39}, {"label": "Tuberculosis", "value": 40}, {"label": "Unvaccinated or not up to date with vaccines", "value": 41}, {"label": "Use of corticosteroids or other immunosuppressive medications", "value": 42}]}, {"type": "radio", "label_en": "<p>eGFR</p>", "name": "egfr2", "default": null, "show_points": false, "optional": false, "conditionality": "age == 1 && disease == 1 && symptoms == 1 && egfr == 1 && impairment == 1 && criteria in [1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43]", "tips_en": "", "options": [{"label": ">60 mL/min", "value": 1}, {"label": ">30 mL/min to <60 mL/min", "value": 2}]}], "chief_complaint_en": ["Cough", "Diarrhea", "Dyspnea", "Fatigue", "Fever", "Headache", "Nausea", "Shortness of Breath", "Sore Throat", "Vomiting"], "specialty_en": ["Critical Care", "Emergency Medicine", "Family Practice", "Infectious Disease", "Internal Medicine", "Pediatrics", "Pharmacy", "Primary Care", "Pulmonology"], "purpose_en": ["Treatment"], "system_en": ["Infectious", "Respiratory"], "disease_en": ["COVID-19"], "tags": [], "versions": [{"id": 10448, "favorite_id": 10444, "calc_type": "diagnostic_criteria", "dosing": true, "full_title_en": "Indications for Paxlovid", "short_title_en": "Indications for Paxlovid", "medium_description_en": "<p>Assists in determining if Paxlovid (ritonovir-boosted nirmatrelvir) is appropriate therapy in a COVID positive adult patient.</p>", "short_description_en": "<p>Paxlovid indication.</p>", "before_use": null, "instructions_en": "<p>In the United States, Paxlovid (ritonovir-boosted nirmatrelvir), is currently availble under the Food and Drug Administration (FDA) Emergency Use Authorization (EUA). This drug status is subject to change.&nbsp;</p>", "slug": "indications-paxlovid-prescribing", "equation_logic": "18fef210e6cc80d00b11466547d4883b", "diagnostic_criteria": true, "createdAt": "2022-12-22T16:44:18.948Z", "updatedAt": "2023-01-03T17:19:31.258Z", "equation_logic_text": "var calc_output = [];\n\nvar age = parseFloat(age);\nvar disease = parseFloat(disease);\nvar symptoms = parseFloat(symptoms);\nvar egfr = parseFloat(egfr);\nvar impairment = parseFloat(impairment);\n\nvar criteria = parseFloat(criteria) || -1;\nvar egfr2 = parseFloat(egfr2) || 0;\n\nvar msg;\n\nif (age == 0 || disease == 0 || symptoms == 0 || egfr == 0 || impairment == 0 || (criteria == -1 && egfr2 == 0)) {\n    msg = 'Paxlovid may not be indicated in this patient.<br/><br/>Refer to NIH treatment guidelines.';\n} \n\nif (criteria != -1 && egfr2 != 0) {\n    if (egfr2 == 1) {\n        msg = 'Paxlovid may be a management option for this patient if they are in the outpatient setting or if they are hospitalized for a reason other than COVID-19 infection.<br/><br/>Prescribe nirmatrelvir 300mg w/ ritonavir 100mg PO BID for 5 days.';\n    }\n    else if (egfr2 == 2) {\n        msg = 'Paxlovid may be a management option for this patient if they are in the outpatient setting or if they are hospitalized for a reason other than COVID-19 infection.<br/><br/>Prescribe nirmatrelvir 150mg w/ ritonavir 100mg PO BID for 5 days.'\n    }\n}\n\ncalc_output.push({\n    name: 'mini',\n    value: '',\n    value_text: '',\n    message: msg\n});\ncalc_output.push({\n    name: 'result',\n    value: '',\n    value_text: '',\n    message: msg\n});", "logic_language": "javascript", "md5": "d08b3e9c470eeee9eef36f44dfa9e3e8", "cmeVersion": null, "cmeReleaseDate": null, "cmeEndDate": null, "cmeLastReviewed": null, "publishedAt": null, "vuid": "b860d12d-f79e-41ed-b37d-4ec3ac559ae7", "versionNumber": 2, "isVisibleInListView": true, "disabled": false, "replacement_calc_id": null, "disabled_reason": null}], "related_calcs": [{"calcId": 10410, "short_title_en": "Utah COVID-19 Risk Score", "slug": "utah-covid19-risk-score"}, {"calcId": 4050, "short_title_en": "DRIP Score", "slug": "drug-resistance-pneumonia-drip-score"}, {"calcId": 3914, "short_title_en": "SMART-COP Score", "slug": "smart-cop-score-pneumonia-severity"}]}